Allianz Asset Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Allianz Asset Management’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-251,521	Closed	-$24.4M	–	2913
2019 Q3	$24.4M	Buy	251,521 +13,730	+6%	+$1.37M	0.02%	696
2019 Q2	$24.3M	Sell	237,791 -33,954	-12%	-$3.66M	0.02%	727
2019 Q1	$30.9M	Buy	271,745 +229,183	+538%	+$16.8M	0.03%	578
2018 Q4	$1.66M	Buy	42,562 +28,617	+205%	+$1.24M	﹤0.01%	1826
2018 Q3	$761K	Buy	+13,945	New	+$954K	﹤0.01%	2298
2015 Q2	–	Sell	-185,580	Closed	-$14.4M	–	2560
2015 Q1	$14.4M	Buy	+185,580	New	+$10.7M	0.02%	804

Allianz Asset Management's ONCE Position: Q4 2019 in Review

Allianz Asset Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 251,521 shares — an estimated $24.4M sold.

Allianz Asset Management first reported a position in ONCE in Q1 2015 and held it in 6 quarters. The position peaked at $30.9M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Allianz Asset Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Allianz Asset Management sold 251,521 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $24.4M.
Allianz Asset Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 6 quarters.
Allianz Asset Management's Spark Therapeutics, Inc. Common Stock position peaked at $30.9M in Q1 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Allianz Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.